Bioinformatics strategies for proteomic profiling

Clinical Biochemistry
C Nicole WhiteZhen Zhang

Abstract

Clinical proteomics is an emerging field that involves the analysis of protein expression profiles of clinical samples for de novo discovery of disease-associated biomarkers and for gaining insight into the biology of disease processes. Mass spectrometry represents an important set of technologies for protein expression measurement. Among them, surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI TOF-MS), because of its high throughput and on-chip sample processing capability, has become a popular tool for clinical proteomics. Bioinformatics plays a critical role in the analysis of SELDI data, and therefore, it is important to understand the issues associated with the analysis of clinical proteomic data. In this review, we discuss such issues and the bioinformatics strategies used for proteomic profiling.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·L Anderson, N G Anderson
Feb 1, 1993·Annals of Internal Medicine·J ConcatoT R Holford
Sep 7, 2000·Current Opinion in Biotechnology·S P GygiR Aebersold
Feb 13, 2001·Current Opinion in Biotechnology·E T FungE A Dalmasso
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·V G TusherG Chu
Feb 12, 2002·Bioinformatics·Danh V Nguyen, David M Rocke
Feb 28, 2002·Lancet·Emanuel F PetricoinLance A Liotta
May 2, 2002·Genome Biology·Jobst LandgrebeGerhard Welzl
Oct 17, 2002·Journal of the National Cancer Institute·Emanuel F PetricoinLance A Liotta
Nov 29, 2002·Archives of Pathology & Laboratory Medicine·Alex J RaiDaniel W Chan
May 2, 2003·Annals of Surgery·William ClarkeErnesto P Molmenti
May 16, 2003·Lancet·Erich HuangAndrew T Huang
Jun 11, 2003·BMC Bioinformatics·James M Sorace, Min Zhan
Jul 26, 2003·Clinical Chemistry·Emanuel Petricoin, Lance A Liotta
Sep 16, 2003·Proteomics·Michael WagnerAlex Pothen
Nov 25, 2003·Annals of Clinical Biochemistry·James O Westgard
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Wei ZhuJohn S Kovach
Dec 12, 2003·Cancer·Yaxin ZhengBrian C-S Liu
Feb 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jens KoopmannMichael Goggins

❮ Previous
Next ❯

Citations

Jun 9, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mario Plebani
May 18, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·David A Colantonio, Daniel W Chan
Dec 6, 2008·BMC Bioinformatics·David A CairnsRosamonde E Banks
Sep 7, 2007·Proteome Science·Toni WhistlerSuzanne D Vernon
Jul 4, 2007·Proteome Science·Dominique RollinSuzanne D Vernon
Nov 29, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Charlotte H ClarkeEric T Fung
Nov 8, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Mario Plebani, Francesco M Marincola
May 19, 2009·Clinical Chemistry and Laboratory Medicine : CCLM·Peter Findeisen, Michael Neumaier
Mar 19, 2009·Proteomics·Vincent A Emanuele, Brian M Gurbaxani
Nov 17, 2010·Proteomics·Laurent GattoKathryn S Lilley
Mar 7, 2006·Biochemical and Biophysical Research Communications·Ira L GoldknopfStanley H Appel
Dec 8, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Judith A P BonsWill K W H Wodzig
Apr 5, 2007·Molecular Cancer·William C S Cho
Jun 2, 2009·Journal of Proteomics·Catherine MercierPascal Roy
Feb 1, 2006·Expert Review of Proteomics·Essam A ShetaIra L Goldknopf
Jun 22, 2005·Expert Review of Proteomics·Dale Vimalachandran, Eithne Costello
Aug 31, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christopher J ScarlettRoss C Smith
Sep 23, 2006·International Journal of Cancer. Journal International Du Cancer·Nicholas P MunroMargaret A Knowles
Mar 29, 2007·Proteomics·Scott M CarlsonHarvey J Cohen
Feb 23, 2005·Expert Review of Molecular Diagnostics·Richard R DrakeJ Trad Wadsworth
Oct 1, 2005·Proteomics·Sarah K Wagg, Lucy E J Lee
Dec 13, 2005·Proteomics·Gyan BhanotArnold J Levine
Jun 15, 2006·Expert Review of Proteomics·Lennard J DekkerTheo M Luider
Jan 20, 2006·Critical Reviews in Biotechnology·Anu Kalia, R P Gupta
Dec 13, 2005·Critical Care Medicine·Gerard T Hoehn, Anthony F Suffredini
Dec 13, 2016·Clinical Biochemistry·Peter A Kavsak
Aug 16, 2005·Analytical Chemistry·Mikkel West-NielsenNiels H H Heegaard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.